Back to Journals » Cancer Management and Research » Volume 10

Abnormal microRNA expression in the course of hematological malignancies

Authors Szymczyk A, Macheta A, Podhorecka M

Received 17 May 2018

Accepted for publication 4 July 2018

Published 8 October 2018 Volume 2018:10 Pages 4267—4277


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Kenan Onel

Agnieszka Szymczyk,1 Arkadiusz Macheta,2 Monika Podhorecka2

1Independent Clinical Transplantology Unit, Medical University of Lublin, Lublin, Poland; 2Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland

Abstract: Research on the carcinogenesis process is currently focused primarily on understanding its genetic basis and molecular abnormalities that may be predictive factors and therapeutic targets. It was clearly confirmed recently that microRNAs are involved in the mechanisms of leukocyte development, differentiation, and apoptosis, as well as in the pathogenesis of proliferative diseases of the hematopoietic system. Currently, research strategies allow determination of the deregulation of microRNA profiles in relation to other cytogenetic aberrations, as well as prognostic factors and primary end points. The problem of the possibility of their use as therapeutic targets is also increasingly discussed. In this article, we analyze literature data on abnormalities in microRNA expression in proliferative diseases of the hematopoietic system in the context of classic cytogenetic and molecular aberrations.

Keywords: hematological malignancies, microRNA, cytogenetic abnormalities

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]